1. Abe Y, Matsuzawa T, Fujiwara T, Fukuda H, Itoh M, Yamada K, Yamaguchi K, Sato T, Ido T (1986) Assessment of radiotherapeutic effects on experimental tumors using18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 12:325?328
2. Ahonen A, Paul R, Aho A, Dean P, Roeda D, Solin O, Virtama P, Ekfors T, Nordman E, Haaparanta M, Wegelius U (1986) Differential diagnosis of bone tumors using fluorodeoxyglucose and three phase99mTc-DPD scanning. In: Schmidt HAE, Ell PJ, Britton KE (eds) Nuclearmedizin. Proc. ENMC. Schattauer, Stuttgart New York, pp 441?443
3. d'Argy R, Paul R, Frankenberg L, Stålnacke CG, Lundqvist H, Kangas L, Halldin C, Någren K, Roeda D, Haaparanta M, Solin O, Långström B (1988) Comparative double-tracer wholebody autoradiography: uptake of11C-,18F-, and3H-labeled compounds in rat tumors. Int J Nucl Med Biol 15:577?585
4. Beaney RP, Lammertsma AA, Jones T, McKenzie CG, Halnan KE (1984) Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet 1:131?134
5. Bolster JM, Vaalburg W, Paans AMJ, van Dijk TH, Elsinga PH, Zijlstra JB, Piers DA, Mulder NH, Woldring MG, Wynberg H (1986) Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET). Eur J Nucl Med 12:321?324